Acceleron Pharma Inc. | Key People and Executives
Habib J. Dable
President, Chief Executive Officer & Director
Francois Nader
Non-Executive Chairman
Karen L. Smith
Independent Director
Thomas A. McCourt
Independent Director
Terrence C. Kearney
Independent Director
Tom Maniatis
Independent Director
Joseph S. Zakrzewski
Independent Director
Richard F. Pops
Lead Independent Director
Jean M. George
Independent Director
Habib J. Dable
President, Chief Executive Officer & Director
Christopher Rovaldi
SVP-Program Management & Operations
Kevin F. McLaughlin
Chief Financial Officer, Treasurer & Senior VP
Robert K. Zeldin
Chief Medical Officer
Ravindra Kumar
Chief Scientific Officer & Senior Vice President
Sujay Kango
Chief Commercial Officer & Senior Vice President
Todd James
VP-Investor Relations & Corporate Communications
John D. Quisel
Secretary, Chief Business Officer & Executive VP
James V. Desiderio
Vice President-Regulatory Affairs
Francois Nader
Non-Executive Chairman
Karen L. Smith
Independent Director
Thomas A. McCourt
Independent Director
Terrence C. Kearney
Independent Director
Tom Maniatis
Independent Director
Joseph S. Zakrzewski
Independent Director
Richard F. Pops
Lead Independent Director
Jean M. George
Independent Director
| Address |
128 Sidney Street
Cambridge Massachusetts 02139
United States
|
|
Employees
|
- |
| Website |
http://www.acceleronpharma.com |
| Updated |
07/08/2019 |
| Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. |
